Bharat Immunologicals (India) Risk Analysis And Volatility Evaluation

BIBCL -- India Stock  

INR 13.11  0.01  0.08%

Macroaxis considers Bharat Immunologicals to be relatively volatile. Bharat Immunologicals secures Sharpe Ratio (or Efficiency) of -0.0189 which signifies that Bharat Immunologicals had -0.0189% of return per unit of standard deviation over the last 1 month. Macroaxis philosophy in foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Bharat Immunologicals Biologicals Corp Ltd exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Bharat Immunologicals Mean Deviation of 3.15 and Risk Adjusted Performance of 0.0267 to double-check risk estimate we provide.
Horizon     30 Days    Login   to change

Bharat Immunologicals Market Sensitivity

As returns on market increase, Bharat Immunologicals returns are expected to increase less than the market. However during bear market, the loss on holding Bharat Immunologicals will be expected to be smaller as well.
One Month Beta |Analyze Bharat Immunologicals Demand Trend
Check current 30 days Bharat Immunologicals correlation with market (DOW)
β = 0.4241

Bharat Immunologicals Central Daily Price Deviation

Bharat Immunologicals Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. Bharat Immunologicals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about avgprice price transform indicator.

Bharat Immunologicals Projected Return Density Against Market

Assuming 30 trading days horizon, Bharat Immunologicals has beta of 0.4241 . This suggests as returns on market go up, Bharat Immunologicals average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Bharat Immunologicals Biologicals Corp Ltd will be expected to be much smaller as well. Moreover, Bharat Immunologicals Biologicals Corp Ltd has an alpha of 0.1113 implying that it can potentially generate 0.1113% excess return over DOW after adjusting for the inherited market risk (beta).
 Predicted Return Density 
      Returns 
Assuming 30 trading days horizon, the coefficient of variation of Bharat Immunologicals is -5285.69. The daily returns are destributed with a variance of 16.64 and standard deviation of 4.08. The mean deviation of Bharat Immunologicals Biologicals Corp Ltd is currently at 3.09. For similar time horizon, the selected benchmark (DOW) has volatility of 1.21
α
Alpha over DOW
=0.11
β
Beta against DOW=0.42
σ
Overall volatility
=4.08
Ir
Information ratio =0.0408

Bharat Immunologicals Return Volatility

Bharat Immunologicals Biologicals Corp Ltd accepts 4.0796% volatility on return distribution over the 30 days horizon. DOW inherits 1.1939% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

Market Risk Breakdown

Bharat Immunologicals Volatility Factors

30 Days Market Risk

Relatively volatile

Chance of Distress in 24 months

Almost imposible

30 Days Economic Sensitivity

Slowly supersedes market

Investment Outlook

Bharat Immunologicals Investment Opportunity

Bharat Immunologicals Biologicals Corp Ltd has a volatility of 4.08 and is 3.43 times more volatile than DOW. 36% of all equities and portfolios are less risky than Bharat Immunologicals. Compared to the overall equity markets, volatility of historical daily returns of Bharat Immunologicals Biologicals Corp Ltd is lower than 36 (%) of all global equities and portfolios over the last 30 days. Use Bharat Immunologicals Biologicals Corp Ltd to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Bharat Immunologicals to be traded at 13.77 in 30 days. As returns on market increase, Bharat Immunologicals returns are expected to increase less than the market. However during bear market, the loss on holding Bharat Immunologicals will be expected to be smaller as well.

Bharat Immunologicals correlation with market

correlation synergy
Average diversification
Overlapping area represents the amount of risk that can be diversified away by holding Bharat Immunologicals Biologic and equity matching DJI index in the same portfolio.

Bharat Immunologicals Volatility Indicators

Bharat Immunologicals Biologicals Corp Ltd Current Risk Indicators

Check also Trending Equities. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Search macroaxis.com